Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010 (2010), Article ID 675320, 6 pages
http://dx.doi.org/10.1155/2010/675320
Research Article

Inflammatory Markers in Middle-Aged Obese Subjects: Does Obstructive Sleep Apnea Syndrome Play a Role?

1Department of Pneumonology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece
2Sleep Unit, Second Chest Department, General Hospital “George Papanikolaou”, 57010 Thessaloniki, Greece
3Outpatient Clinic of Obesity, Diabetes and Metabolism, Second Department of Internal Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece
4Immunology Laboratory, General Hospital “George Papanikolaou”, 57010 Thessaloniki, Greece

Received 16 December 2009; Accepted 11 April 2010

Academic Editor: Oreste Gualillo

Copyright © 2010 Paschalis Steiropoulos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Young, M. Palta, J. Dempsey, J. Skatrud, S. Weber, and S. Badr, “The occurrence of sleep-disordered breathing among middle-aged adults,” New England Journal of Medicine, vol. 328, no. 17, pp. 1230–1235, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. W. T. McNicholas and M. R. Bonsignore, “Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities,” European Respiratory Journal, vol. 29, pp. 156–178, 2007. View at Google Scholar
  3. R. J. O. Davies and J. R. Stradling, “The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apneoa syndrome,” European Respiratory Journal, vol. 3, no. 5, pp. 509–514, 1990. View at Google Scholar · View at Scopus
  4. E. Shinohara, S. Kihara, S. Yamashita et al., “Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects,” Journal of Internal Medicine, vol. 241, no. 1, pp. 11–18, 1997. View at Google Scholar · View at Scopus
  5. T. Young, P. E. Peppard, and D. J. Gottlieb, “Epidemiology of obstructive sleep apnea: a population health perspective,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 9, pp. 1217–1239, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Young, P. E. Peppard, and S. Taheri, “Excess weight and sleep-disordered breathing,” Journal of Applied Physiology, vol. 99, no. 4, pp. 1592–1599, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Alam, K. Lewis, J. W. Stephens, and J. N. Baxter, “Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states,” Obesity Reviews, vol. 8, no. 2, pp. 119–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Fantuzzi and T. Mazzone, “Adipose tissue and atherosclerosis: exploring the connection,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 5, pp. 996–1003, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. B. J. Arsenault, A. Cartier, M. Côté et al., “Body composition, cardiorespiratory fitness and low-grade inflammation in middle-aged men and women,” American Journal of Cardiology, vol. 104, no. 2, pp. 240–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Fantuzzi, “Adipose tissue, adipokines, and inflammation,” Journal of Allergy and Clinical Immunology, vol. 115, no. 5, pp. 911–920, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Ryan, C. T. Taylor, and W. T. McNicholas, “Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?” Thorax, vol. 64, no. 7, pp. 631–636, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. E. S. Arnardottir, M. Mackiewicz, T. Gislason, K. L. Teff, and A. I. Pack, “Molecular signatures of obstructive sleep apnea in adults: a review and perspective,” Sleep, vol. 32, no. 4, pp. 447–470, 2009. View at Google Scholar · View at Scopus
  13. V. Tsara, E. Serasli, A. Amfilochiou, T. Constantinidis, and P. Christaki, “Greek version of the Epworth Sleepiness Scale,” Sleep and Breathing, vol. 8, no. 2, pp. 91–95, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Iber, S. Ancoli-Israel, A. L. Chesson, and S. F. Quan, The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Technical Specifications, American Academy of Sleep Medicine, Westchester, Ill, USA, 2007.
  15. T. U. Ciftci, O. Kokturk, N. Bukan, and A. Bilgihan, “The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome,” Cytokine, vol. 28, no. 2, pp. 87–91, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Minoguchi, T. Tazaki, T. Yokoe et al., “Elevated production of tumor necrosis factor-a by monocytes in patients with obstructive sleep apnea syndrome,” Chest, vol. 126, no. 5, pp. 1473–1479, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Ryan, C. T. Taylor, and W. T. McNicholas, “Predictors of elevated nuclear factor-κB-dependent genes in obstructive sleep apnea syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 7, pp. 824–830, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. N. Vgontzas, E. Zoumakis, E. O. Bixler et al., “Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 5, pp. 2119–2126, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. A. N. Vgontzas, E. Zoumakis, H.-M. Lin, E. O. Bixler, G. Trakada, and G. P. Chrousos, “Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-α antagonist,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 9, pp. 4409–4413, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. A. N. Vgontzas, D. A. Papanicolaou, E. O. Bixler, A. Kales, K. Tyson, and G. P. Chrousos, “Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 5, pp. 1313–1316, 1997. View at Google Scholar · View at Scopus
  21. A. S. M. Shamsuzzaman, M. Winnicki, P. Lanfranchi et al., “Elevated C-reactive protein in patients with obstructive sleep apnea,” Circulation, vol. 105, no. 21, pp. 2462–2464, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Can, S. Acikgoz, G. Mungan et al., “Serum cardiovascular risk factors in obstructive sleep apnea,” Chest, vol. 129, no. 2, pp. 233–237, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Saletu, D. Nosiska, G. Kapfhammer et al., “Structural and serum surrogate markers of cerebrovascular disease in obstructive sleep apnea (OSA): association of mild OSA with early atherosclerosis,” Journal of Neurology, vol. 253, no. 6, pp. 746–752, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Yokoe, K. Minoguchi, H. Matsuo et al., “Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure,” Circulation, vol. 107, no. 8, pp. 1129–1134, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Barcelo, F. Barbe, E. Llompart et al., “Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea,” American Journal of Medicine, vol. 117, no. 2, pp. 118–121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Guilleminault, C. Kirisoglu, and M. M. Ohayon, “C-reactive protein and sleep-disordered breathing,” Sleep, vol. 27, no. 8, pp. 1507–1511, 2004. View at Google Scholar · View at Scopus
  27. T. Akashiba, T. Akahoshi, S. Kawahara, T. Majima, and T. Horie, “Effects of long-term nasal continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea syndrome,” Internal Medicine, vol. 44, no. 8, pp. 899–900, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Ryan, G. M. Nolan, E. Hannigan, S. Cunningham, C. Taylor, and W. T. McNicholas, “Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity,” Thorax, vol. 62, no. 6, pp. 509–514, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Ryan and W. T. McNicholas, “Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS,” Archives of Physiology and Biochemistry, vol. 114, no. 4, pp. 261–266, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Mehra, A. Storfer-Isser, H. L. Kirchner et al., “Soluble interleukin 6 receptor: a novel marker of moderate to severe sleep-related breathing disorder,” Archives of Internal Medicine, vol. 166, no. 16, pp. 1725–1731, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Steiropoulos, V. Tsara, E. Nena et al., “Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome,” Chest, vol. 132, no. 3, pp. 843–851, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. T. E. Wessendorf, A. F. Thilmann, Y.-M. Wang, A. Schreiber, N. Konietzko, and H. Teschler, “Fibrinogen levels and obstructive sleep apnea in ischemic stroke,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 6, pp. 2039–2042, 2000. View at Google Scholar · View at Scopus
  33. R. Tkacova, Z. Dorkova, A. Molcanyiova, Z. Radikova, I. Klimes, and I. Tkac, “Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea,” Medical Science Monitor, vol. 14, no. 9, pp. CR438–CR444, 2008. View at Google Scholar · View at Scopus
  34. N. Peled, M. Kassirer, M. R. Kramer et al., “Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome,” Thrombosis Research, vol. 121, no. 5, pp. 631–636, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Ryan, C. T. Taylor, and W. T. McNicholas, “Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome,” Circulation, vol. 112, no. 17, pp. 2660–2667, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Hoffstein and J. P. Szalai, “Predictive value of clinical features in diagnosing obstructive sleep apnea,” Sleep, vol. 16, no. 2, pp. 118–122, 1993. View at Google Scholar · View at Scopus
  37. T. Rankinen, S.-Y. Kim, L. Pérusse, J.-P. Després, and C. Bouchard, “The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis,” International Journal of Obesity, vol. 23, no. 8, pp. 801–809, 1999. View at Google Scholar · View at Scopus
  38. J.-P. Despres, “Cardiovascular disease under the influence of excess visceral fat,” Critical Pathways in Cardiology, vol. 6, no. 2, pp. 51–59, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Steiropoulos, I. Kotsianidis, E. Nena et al., “Long-term effect of continuous positive airway pressure therapy on infammation markers of patients with obstructive sleep apnea syndrome,” Sleep, vol. 32, no. 4, pp. 537–543, 2009. View at Google Scholar · View at Scopus